183 related articles for article (PubMed ID: 18347932)
1. Tumor characteristics in screen-detected and symptomatic breast cancers.
Pálka I; Kelemen G; Ormándi K; Lázár G; Nyári T; Thurzó L; Kahán Z
Pathol Oncol Res; 2008 Jun; 14(2):161-7. PubMed ID: 18347932
[TBL] [Abstract][Full Text] [Related]
2. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of HER 2 positive small invasive (T1a,b) breast cancer: "A wolf in sheep's clothing".
Bezić J; Šamija Projić I; Projić P; Meljanac Salopek K; Živković PM; Božić J; Tomić S
Pathol Res Pract; 2017 Dec; 213(12):1510-1514. PubMed ID: 29033181
[TBL] [Abstract][Full Text] [Related]
4. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
7. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
Yang WT; Dryden M; Broglio K; Gilcrease M; Dawood S; Dempsey PJ; Valero V; Hortobagyi G; Atchley D; Arun B
Breast Cancer Res Treat; 2008 Oct; 111(3):405-10. PubMed ID: 18026834
[TBL] [Abstract][Full Text] [Related]
8. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
Yaghjyan L; Colditz GA; Collins LC; Schnitt SJ; Rosner B; Vachon C; Tamimi RM
J Natl Cancer Inst; 2011 Aug; 103(15):1179-89. PubMed ID: 21795664
[TBL] [Abstract][Full Text] [Related]
9. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
10. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.
Gajdos C; Tartter PI; Bleiweiss IJ; Hermann G; de Csepel J; Estabrook A; Rademaker AW
Ann Surg; 2002 Feb; 235(2):246-51. PubMed ID: 11807365
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
[TBL] [Abstract][Full Text] [Related]
12. Effect of adjuvant chemotherapy in patients with ER + /HER2- breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status.
Tanaka N; Hirano A; Hattori A; Ogura K; Kamimura M; Inoue H; Yukawa H; Sakaguchi S; Matsuoka A; Kodera A; Shimizu T
Breast Cancer; 2021 Jan; 28(1):40-47. PubMed ID: 32592141
[TBL] [Abstract][Full Text] [Related]
13. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
Majid S; Rydén L; Manjer J
World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
[TBL] [Abstract][Full Text] [Related]
15. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
16. Detecting which invasive cancers at mammographic screening saves lives?
Evans AJ; Pinder SE; Burrell HC; Ellis IO; Wilson AR
J Med Screen; 2001; 8(2):86-90. PubMed ID: 11480449
[TBL] [Abstract][Full Text] [Related]
17. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.
Porter PL; El-Bastawissi AY; Mandelson MT; Lin MG; Khalid N; Watney EA; Cousens L; White D; Taplin S; White E
J Natl Cancer Inst; 1999 Dec; 91(23):2020-8. PubMed ID: 10580027
[TBL] [Abstract][Full Text] [Related]
18. Association between mammographic breast density and breast cancer tumor characteristics.
Aiello EJ; Buist DS; White E; Porter PL
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):662-8. PubMed ID: 15767347
[TBL] [Abstract][Full Text] [Related]
19. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance?
Killelea BK; Chagpar AB; Bishop J; Horowitz NR; Christy C; Tsangaris T; Raghu M; Lannin DR
Ann Surg Oncol; 2013 Oct; 20(10):3247-53. PubMed ID: 23975299
[TBL] [Abstract][Full Text] [Related]
20. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients.
Pálka I; Ormándi K; Gaál S; Boda K; Kahán Z
Acta Oncol; 2007; 46(8):1178-83. PubMed ID: 17851833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
